Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Russell Angus C. Create: Alert

All | News | Filings
Date FiledTypeDescription
07/03/2023 4 Russell Angus C. (Director) has filed a Form 4 on Lineage Cell Therapeutics, Inc.
Txns: Granted 50,000 options to buy @ $1.41, valued at $70.5k
05/05/2023 4 Russell Angus C. (Director) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 3,534 shares @ $0
Granted 5,915 options to buy @ $33.61, valued at $198.8k
10/03/2022 4 Russell Angus C. (Director) has filed a Form 4 on TherapeuticsMD, Inc.
Txns: Granted 5,000 restricted stock units @ $0
08/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/13/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
05/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/16/2020 4 Russell Angus C. (Director) has filed a Form 4 on Mallinckrodt plc
Txns: Sold 51,789 shares @ $0.1287, valued at $6.7k
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/19/2020 4 Russell Angus C. (Director) has filed a Form 4 on TherapeuticsMD, Inc.
Txns: Granted 96,864 restricted stock units @ $0
05/15/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/15/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/26/2019 4 Russell Angus C. (Director) has filed a Form 4 on TherapeuticsMD, Inc.
Txns: Bought 10,000 shares @ $2.77, valued at $27.7k
08/15/2019 4 Russell Angus C. (Director) has filed a Form 4 on TherapeuticsMD, Inc.
Txns: Bought 25,000 shares @ $2.76, valued at $69k
Bought 10,000 shares @ $2.99, valued at $29.9k
07/03/2019 4 Russell Angus C. (Director) has filed a Form 4 on BIOTIME INC
Txns: Granted 40,000 options to buy @ $1.03, valued at $41.2k
06/24/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2019 4 Russell Angus C. (Director) has filed a Form 4 on Mallinckrodt plc
Txns: Paid exercise price by delivering 11,764 shares @ $15.21, valued at $178.9k
Granted 26,759 shares @ $0
05/10/2019 4 Russell Angus C. (Director) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 4,500 shares @ $0
Granted 9,000 options to buy @ $12.82, valued at $115.4k
07/05/2018 4 Russell Angus C. (Director) has filed a Form 4 on TherapeuticsMD, Inc.
Txns: Granted 50,000 options to buy @ $6.35, valued at $317.5k
07/03/2018 4 Russell Angus C. (Director) has filed a Form 4 on BIOTIME INC
Txns: Granted 40,000 options to buy @ $2.06, valued at $82.4k
05/18/2018 4 Russell Angus C. (Director) has filed a Form 4 on Mallinckrodt plc
Txns: Granted 26,141 shares @ $0
05/11/2018 4 Russell Angus C. (Director) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 3,000 shares @ $0
Granted 6,000 options to buy @ $29.15, valued at $174.9k
03/05/2018 4 Russell Angus C. (Director) has filed a Form 4 on Mallinckrodt plc
Txns: Paid exercise price by delivering 2,576 shares @ $15.68, valued at $40.4k
10/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/23/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/12/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy